Prominent Vendors in The Global Breast Biopsy Device Market.

The global breast biopsy device market is expected to grow at a CAGR of 10.19% during the forecast period. Some of the prominent vendors in the market include Argon Medical Devices Inc., Becton, Dickinson and Co., Carestream Health Inc., Danaher Corp., FUJIFILM Holdings Corp., General Electric Co., Hologic Inc., Planmed Oy, Scion Medical Technologies LLC, Siemens Healthineers AG, and among others.

The prominent vendors in the market are focusing on expanding and strengthening their product offerings by obtaining approval from regulatory bodies for the commercialization of their products and are showcasing these products at various conferences. The companies are obtaining regulatory approvals, which can aid them in expanding their product portfolios. Some of the products in the breast biopsy device that have received regulatory approval and have been showcased by vendors.

Request for: Free Sample Report

In June 2019, FUJIFILM Holdings received US FDA 510(k) approval for its Biopsy Positioner, which is a mammographic X-ray system, which provides an accurate 3D image of the location of lesions in the breast using information extracted from stereotactic pairs of 2D images and DBT. The product is used for interventional purposes, such as biopsy, pre-surgical localization, and treatment. Hence, the increasing number of products showcasing and approvals are expected to drive the global breast biopsy device market during the forecast period.